✦ LIBER ✦

The Lipid-Altering Effects of Extended-Release Niacin/Laropiprant Among Different Patient Subgroups

✍ Scribed by Harold Edward Bays; Alexandra MacLean; Arvind Shah; Christine McCrary Sisk; Qian Dong; Darbie Maccubbin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended Release Niacin/Laropiprant Lowe

✍ Harold Edward Bays; Christie Ballantyne; Arvind Shah; Christine McCrary Sisk; Qi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 44 KB

106 EXTENDED RELEASE NIACIN/LAROPIPRANT

✍ Ballantyne, C.M.; Bays, H.E.; Shah, A.K.; Sisk, C.; Dong, Q.; Maccubbin, D. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

LIPID-ALTERING EFFICACY AND SAFETY PROFI

✍ Farnier, M.; Ose, L.; Gleim, G.; Liu, N.; Thompson-Bell, S.; Beckey, K.; Johnson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Lipid-modifying efficacy of extended rel

✍ Debra Kush; Hyo-Soo Kim; Da Yi Hu; Ji Liu; Waheeda Sirah; Aditi Sapre; Christine 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 254 KB

Lipid-modifying efficacy and tolerabilit

✍ D. Maccubbin; H. E. Bays; A. G. Olsson; V. Elinoff; A. Elis; Y. Mitchel; W. Sira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

Extended-Release Niacin/Laropiprant Sign

✍ Harold E. Bays; Eliot A. Brinton; Joseph Triscari; Erluo Chen; Darbie Maccubbin; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 62 KB